Development and Manufacturing - Company Ranking(44 companies in total)
Last Updated: Aggregation Period:Nov 05, 2025〜Dec 02, 2025
This ranking is based on the number of page views on our site.
Display Company Information
| Company Name | Featured Products | ||
|---|---|---|---|
| Product Image, Product Name, Price Range | overview | Application/Performance example | |
| 1. Production Technology - Production in compliance with PIC/S GMP certified by Sterility Assurance Levels (SAL) - Adoption of single-use te... | 1. Active Pharmaceutical Ingredient Manufacturing - Production of low molecular weight peptides and peptide-drug conjugates (PDCs) 2. For... | ||
| **Main Capabilities of Mycenax** - End-to-end biopharmaceutical development and manufacturing - Full-service offerings from Proof-of-Concept... | 【Usage】 ■ Supports batch sizes from 1,000 to 100,000 vials ■ Robust quality control system ■ Operations compliant with PIC/S GMP and in acco... | ||
| **Main Capabilities of Mycenax** - End-to-end biopharmaceutical development and manufacturing - Full-service offerings from Proof-of-Concept... | 【Usage】 ■ Supports batch sizes from 1,000 to 100,000 vials ■ Robust quality control system ■ Operations compliant with PIC/S GMP, adhering t... | ||
|
---
--- |
--- | ||
-
- Featured Products
-
Contract services for research and development and manufacturing of synthetic pharmaceuticals.
- overview
- 1. Production Technology - Production in compliance with PIC/S GMP certified by Sterility Assurance Levels (SAL) - Adoption of single-use te...
- Application/Performance example
- 1. Active Pharmaceutical Ingredient Manufacturing - Production of low molecular weight peptides and peptide-drug conjugates (PDCs) 2. For...
[Contract Services] ADC (Antibody-Drug Conjugate) Contract Development and Manufacturing
- overview
- **Main Capabilities of Mycenax** - End-to-end biopharmaceutical development and manufacturing - Full-service offerings from Proof-of-Concept...
- Application/Performance example
- 【Usage】 ■ Supports batch sizes from 1,000 to 100,000 vials ■ Robust quality control system ■ Operations compliant with PIC/S GMP and in acco...
Contract services for the development and manufacturing of monoclonal antibody (mAb) pharmaceuticals.
- overview
- **Main Capabilities of Mycenax** - End-to-end biopharmaceutical development and manufacturing - Full-service offerings from Proof-of-Concept...
- Application/Performance example
- 【Usage】 ■ Supports batch sizes from 1,000 to 100,000 vials ■ Robust quality control system ■ Operations compliant with PIC/S GMP, adhering t...
-
Membership (free) is required to view all content.
Already a Member? Log In Here
リブラメディシーナ